GeNeuro S.A.
GNRO.PA · PAR
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | – | – | – |
| R&D Expenses | €12 | €10 | €5 | €5 |
| G&A Expenses | €3 | €0 | €0 | €0 |
| SG&A Expenses | €3 | €3 | €2 | €3 |
| Sales & Mktg Exp. | €0 | €3 | €2 | €3 |
| Other Operating Expenses | -€0 | €0 | -€0 | €0 |
| Operating Expenses | €15 | €13 | €7 | €8 |
| Operating Income | -€14 | -€13 | -€8 | -€8 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -€1 | -€0 | -€0 | -€1 |
| Pre-Tax Income | -€15 | -€14 | -€8 | -€10 |
| Tax Expense | -€1 | -€1 | -€1 | -€1 |
| Net Income | -€15 | -€12 | -€7 | -€9 |
| % Margin | – | – | – | – |
| EPS | -0.59 | -0.51 | -0.32 | -0.45 |
| % Growth | -15.7% | -59.4% | 28.9% | – |
| EPS Diluted | -0.59 | -0.51 | -0.32 | -0.45 |
| Weighted Avg Shares Out | 25 | 24 | 21 | 20 |
| Weighted Avg Shares Out Dil | 25 | 24 | 21 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €1 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€14 | -€13 | -€7 | -€9 |
| % Margin | – | – | – | – |